MDM2-ALT2 and Its Role in Liposarcoma
Author Information
Author(s): de Faria Fernanda Costas C., Khurshid Safiya, Sarchet Patricia, Tahara Sayumi, Casadei Lucia, Grignol Valerie, Karna Roma, Rentsch Sydney, Sp Nipin, Beane Joal D., Mazzoccoli Luciano, Montes Matias, Nigita Giovanni, Sharick Joe T., Leight Jennifer L., Calore Federica, Chandler Dawn S., Pollock Raphael E.
Primary Institution: The Ohio State University Wexner Medical Center
Hypothesis
MDM2-ALT2 may promote progression in retroperitoneal liposarcoma (RPLPS).
Conclusion
MDM2-ALT2 overexpression in DDLPS cells leads to increased proliferation, migration, and invasion, suggesting its oncogenic role in RPLPS.
Supporting Evidence
- MDM2-ALT2 expression levels were significantly higher in tumor tissues compared to normal adjacent tissues.
- Overexpression of MDM2-ALT2 in DDLPS cells led to increased proliferation and migration.
- AKT inhibition reduced the oncogenic effects of MDM2-ALT2 in DDLPS cells.
Takeaway
Researchers found that a specific version of a gene called MDM2, known as MDM2-ALT2, helps cancer cells grow and spread in a type of cancer called liposarcoma.
Methodology
The study assessed MDM2-ALT2 expression in RPLPS patient samples and evaluated its biological functions in DDLPS cell lines using qPCR and BaseScope™.
Limitations
The study is limited by the small sample size and the need for further validation in larger cohorts.
Participant Demographics
The study included 38 patients with retroperitoneal liposarcoma.
Statistical Information
P-Value
p = 0.0164
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website